Literature DB >> 8423017

Radiosensitization of uterine cancer cell lines by cytotoxic agents.

H N Nguyen1, B U Sevin, H E Averette, C Gottlieb, J Perras, D Donato, M Penalver.   

Abstract

Radiotherapy remains an integral part of uterine cancer therapy. Overcoming radioresistant tumors by sensitizers continues to be a prime objective in radiotherapy research. In this study, the effects of five cytotoxic agents on two radiosensitive and four radioresistant uterine cancer cell lines were investigated. The ATP bioluminescence was used to measure surviving fractions. Data analysis was done using the linear quadratic model and radiosensitivity index D. Both AN3 and SKUT1B were radiosensitive with Ds of 1.73 and 1.72 Gy, respectively. The resistant cell lines had the following D values: AE7, 3.50; ECC, 6.61; HEC1A, 4.59; and HEC1B, 13.49 Gy. The average radiosensitization effects for various drugs were measured by reduction of D: DXR 45 +/- 7, DDP 40 +/- 9, 5FU 55 +/- 10, MITO 59 +/- 14, and HU 1.7 +/- 7%. Except for HU, Wilcoxon analyses revealed that these sensitizing effects were significant with P < 0.02. In summary, Adriamycin, 5-fluorouracil, cisplatin, and mitomycin-C have the potential to be radiosensitizers in uterine cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423017     DOI: 10.1006/gyno.1993.1004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Mitotic catastrophe is a putative mechanism underlying the weak correlation between sensitivity to carbon ions and cisplatin.

Authors:  Daijiro Kobayashi; Takahiro Oike; Atsushi Shibata; Atsuko Niimi; Yoshiki Kubota; Makoto Sakai; Napapat Amornwhichet; Yuya Yoshimoto; Yoshihiko Hagiwara; Yuka Kimura; Yuka Hirota; Hiro Sato; Mayu Isono; Yukari Yoshida; Takashi Kohno; Tatsuya Ohno; Takashi Nakano
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

2.  Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.